Announced Tue, 11 Aug, 2026 · 17:09 IST
Mudra Financial Q1 FY27 results, MD re-appointment and AGM notice
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
Board approved Q1 FY27 unaudited results on Aug 11, 2026. Reviewed by Sampat and Mehta LLP with a clean limited review report, no qualifications. The board also re-appointed MD Dipen Maheshwari for 3 years from April 1, 2027, subject to shareholder approval. The 32nd AGM is scheduled for September 17, 2026.
Likely market impact
Clean review report. MD continuity confirmed for 3 years. AGM set for September 17, 2026.